Biol Psychiatry 55, 85-90, (2004). Miyatake, R., Furukawa, A., Matsushita, S., Higuchi, S., & Suwaki, H. View abstract in PubMed Post navigationPreviousPrevious post:Sigma-1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats.NextNext post:The sigma receptor ligand (+)pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate.Related PostsAnavex Life Sciences Reports Recent Data Review by the Independent Data Safety Monitoring Board for its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients with Rett SyndromeJuly 31, 2019Anavex Life Sciences Receives Positive Opinion for Orphan Designation from the European Medicines Agency for ANAVEX®2-73 for the Treatment of Rett SyndromeJuly 29, 2019Anavex Life Sciences to Present at the 30th Annual ROTH ConferenceMarch 9, 2018Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018
Anavex Life Sciences Reports Recent Data Review by the Independent Data Safety Monitoring Board for its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients with Rett SyndromeJuly 31, 2019
Anavex Life Sciences Receives Positive Opinion for Orphan Designation from the European Medicines Agency for ANAVEX®2-73 for the Treatment of Rett SyndromeJuly 29, 2019
Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018
